The Company forms long-term collaborations with healthcare institutions, universities and industrial firms, combining expertise from both the public and private sectors to support the ultimate aim of constantly improving the quality of patient outcomes.
bioMérieux, a founding member of BIOASTER
Following the initiative of the French government, BIOASTER Technology Research Institute (TRI) was created in April 2012 by Institut Pasteur and Lyonbiopole health competitiveness cluster, and is working to support the latest challenges in microbiology. Its 4 objectives are to:
- fight against antimicrobial resistance,
- improve vaccine safety and efficacy,
- quickly diagnose infections at the patient’s bedside,
- take full advantage of the human and animal microbiota.
In order to explore new technological avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around technology units and programs of excellence.
Following the Institut Mérieux in 2012, bioMérieux joined the group of BIOASTER founders in May 2018.
The strong partnership between bioMérieux, BIOASTER and their academic counterparts allows us to be more responsive to the fast pace of innovation in the research sector, by combining the partners’ individual technological and scientific expertise to collectively address the industry’s medical research needs. This partnership offers all the necessary ingredients for effective translational research.
Nathalie Garçon, CEO & CSO, BIOASTER